|
FOXN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.07680000050703E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.28970000234929E-08 |
| Normal-vs-Stage2 |
4.858000E-02 |
| Normal-vs-Stage3 |
1.764400E-02 |
| Normal-vs-Stage4 |
9.186000E-02 |
| Stage1-vs-Stage2 |
9.126600E-01 |
| Stage1-vs-Stage3 |
2.376000E-02 |
| Stage1-vs-Stage4 |
7.354100E-04 |
| Stage2-vs-Stage3 |
3.979400E-01 |
| Stage2-vs-Stage4 |
2.108400E-01 |
| Stage3-vs-Stage4 |
4.251800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.12609999997271E-07 |
| Normal-vs-AfricanAmerican |
9.967000E-01 |
| Normal-vs-Asian |
4.838100E-02 |
| Caucasian-vs-AfricanAmerican |
5.7430000000025E-05 |
| Caucasian-vs-Asian |
4.129700E-02 |
| AfricanAmerican-vs-Asian |
4.947700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.48819999995698E-06 |
| Normal-vs-Female |
8.35940000000202E-05 |
| Male-vs-Female |
6.768400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.568400E-02 |
| Normal-vs-Age(41-60Yrs) |
9.62280000016413E-07 |
| Normal-vs-Age(61-80Yrs) |
1.818290E-04 |
| Normal-vs-Age(81-100Yrs) |
3.562200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.171800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.100000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.189800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.256300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.410400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.975000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.544300E-03 |
| Normal-vs-Grade 2 |
7.69819999968391E-08 |
| Normal-vs-Grade 3 |
1.824590E-03 |
| Normal-vs-Grade 4 |
1.804600E-01 |
| Grade 1-vs-Grade 2 |
5.539600E-01 |
| Grade 1-vs-Grade 3 |
9.795200E-03 |
| Grade 1-vs-Grade 4 |
1.285860E-02 |
| Grade 2-vs-Grade 3 |
1.379180E-03 |
| Grade 2-vs-Grade 4 |
1.184140E-03 |
| Grade 3-vs-Grade 4 |
3.003600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.01470009750938E-11 |
| Normal-vs-ccB subtype |
4.864300E-03 |
| ccA subtype-vs-ccB subtype |
2.152900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.55100000000164E-05 |
| Normal-vs-N1 |
1.989230E-01 |
| N0-vs-N1 |
8.270600E-01 |
|
|
